AI-14 THE ANTI ANGIOGENIC AND INVASIVE EFFECTS OF AN INTEGRIN INHIBITOR AGAINST BEVACIZUMAB-INDUCED INVASIVE GLIOMA

Glioblastoma is known to secrete high levels of vascular endothelial growth factor (VEGF), and clinical studies with bevacizumab, a monoclonal antibody to VEGF, have demonstrated convincing therapeutic benefits in patients with glioblastoma. However, its induction of invasive proliferation has also...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Ishida, Joji, Onishi, Manabu, Kurozumi, Kazuhiko, Ichikawa, Tomotsugu, Fujii, Kentaro, Shimazu, Yosuke, Oka, Tetsuo, Otani, Yoshihiro, Shimizu, Toshihiko, Date, Isao
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2014
Gaiak:
Abstracts
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4217852/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou238.14
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak